Latest News

02.22.19

EyeBrain Medical and IDOC Announce Partnership to Bring Neurolens to IDOC Independent Optometrists

Source: IDOC

02.22.19

Health Burden of Glaucoma Has Risen Worldwide

Source: Acta Opthalmologica

02.22.19

Morphic Therapeutic Enters Into Integrin Research and Development Collaboration with J&J’s Janssen

Source: Morphic Therapeutic

02.21.19

Ocular Therapeutix Announces Dosing of First Patient in Phase 1 Clinical Trial for the Treatment of Wet AMD

Source: Ocular Therapeutix

02.21.19

Allergan Responds to Public Shareholder Letter

Source: Allergan

02.21.19

Ophtec’s Preloaded Capsular Tension Ring Ringject Receives Approval in China

Source: Ophtec

02.20.19

ReNeuron Group Announces Positive Preliminary Data in US Retinitis Pigmentosa Trial

Source: ReNeuron Group

02.20.19

Alembic Pharmaceuticals Announces FDA Approval for Glaucoma Treatment Acetazolamide

Source: Alembic Pharmaceuticals

02.20.19

RightEye Introduces Functional Vision EyeQ Automated Test

Source: RightEye

02.20.19

AbbVie’s Humira (Adalimumab) Approved by Health Canada to Treat Pediatric Patients with Chronic Noninfectious Anterior Uveitis

Source: AbbVie

02.20.19

Bruder Introduces Hygienic Eyelid Solution

Source: Bruder Healthcare

02.19.19

Bausch + Lomb Acquires Eton Pharmaceuticals’ EM-100 Investigational OTC Eye Drop For Allergic Conjunctivitis

Source: Bausch Health Companies

02.19.19

Essilor Vision Foundation Collaborates With Government of Maharashtra to Support a Free Vision Care Program for 2.5 Million Children in Need

Source: Essilor

02.19.19

College of Optometrists in Vision Development & NORA Issue Joint Recommendation for Optometric Evaluation Following Brain Injury

Source: The College of Optometrists in Vision Development

02.18.19

MacuLogix Relocates to Larger Headquarters in Harrisburg, Pennsylvania to Accommodate Growth

Source: MacuLogix

View more stories